A new study announced Wednesday shows that psilocybin -- the active compound in "magic mushrooms" -- and mindfulness training ...

Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a ...

Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a ...

Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

Penn Medicine researchers have discovered that psilocybin, a natural compound found in some psychedelic mushrooms, can relieve depression and chronic pain with a single dose.

Nearly half (46%) of healthcare workers who received psilocybin and meditation techniques were free of depression at 2 weeks, compared to just 8% who only did meditation ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help reduce depressive symptoms in people with bipolar II disorder who have not ...

Two distantly related groups of mushrooms take radically different routes to producing psilocybin, a mind-bending molecule.